An Ecological Momentary Assessment Based Program to Support Self-Management for Post-stroke Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Hong Kong Polytechnic University

About this trial

The goal of this feasibility study is to test whether a new approach that combines real-time symptom tracking (Ecological Momentary Assessment) with machine learning can help people recovering from a stroke to better manage depression, thinking difficulties, and daily functioning. The main questions it aims to answer are:

Is this combined approach practical and acceptable for post-stroke survivors? Does the program improve mood, cognitive function, or functional ability to carry out daily activities?

Participants will:

Use a smartphone app called RehabCare Companion for a period of time Answer brief daily surveys about their mood, thoughts, and activities for one week Receive personalized self-care suggestions generated by machine learning based on their responses Complete assessments of depression, cognition, and functioning before and after the program Take part in a group interview to share their experiences

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

adults aged 18 years or older

having a confirmed diagnosis of stroke

having sufficient proficiency in Cantonese to understand and respond to the assessments and prompts

having a Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) score of 18 or higher

Disqualifiers

they have moderate to severe cognitive impairment (a HK-MoCA score of 17 or lower)

they have active psychiatric disorders other than depression (e.g., schizophrenia, bipolar disorder)

they have a terminal illness or prognosis that suggests a limited life expectancy

they have conditions that compromise their self-care ability (i.e., bedbound).

Trial design

Design model

Single group

Treatments tested in this trial

  • Ecological Momentary Assessment based Self-management Program

    Behavioral

    The research team collects participants' EMA data (ie., depression, cognitive function, daily activity, and contextual data) from participants for 7-day and analyze the data by machine learning in the first phase, while provide real-time, individualized, self-care messages to the participants via a personalized self-care AI app in the second phase.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Ecological Momentary Assessment based Self-management ProgramExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility of the study: acceptance

The acceptance of participants to the program will be measured by recruitment rate, attrition rate, and retention rate.

Time frame
Immediately after the intervention (T2).
2

Feasibility of the study: adherence

The adherence of the participants will be evaluated by using the percentage of completed EMA assessments and the frequency of app usage.

Time frame
Immediately after the intervention (T2).
3

Feasibility of the study: experience of the participants in using the app

Participants' experience will be assessed through individual interviews.

Time frame
Immediately after the intervention (T2).

Secondary outcomes

1

Preliminary effectiveness: depression Levels

Beck Depression Inventory (BDI) will be used to assess the depression levels of post-stroke patients.

Time frame
Pre-intervention (T1) and immediately after the intervention (T2).
2

Preliminary effectiveness: cognitive function

Cognitive function will be screened using Montreal Cognitive Assessment Hong Kong version (HK-MoCA).

Time frame
Pre-intervention (T1) and immediately after the intervention (T2).
3

Preliminary effectiveness: disability and functioning

The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a widely used instrument for assessing disability and functioning in individuals.

Time frame
Pre-intervention (T1) and immediately after the intervention (T2).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.